Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial.

MLA

Solli, Kristin Klemmetsby, et al. “Effectiveness, Safety and Feasibility of Extended‐release Naltrexone for Opioid Dependence: A 9‐month Follow‐up to a 3‐month Randomized Trial.” Addiction, vol. 113, no. 10, Oct. 2018, pp. 1840–49. EBSCOhost, https://doi.org/10.1111/add.14278.

APA

Solli, K. K., Latif, Z., Opheim, A., Krajci, P., Sharma, H. K., Benth, J. Š., Tanum, L., & Kunoe, N. (2018). Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial. Addiction, 113(10), 1840–1849. https://doi.org/10.1111/add.14278

Chicago

Solli, Kristin Klemmetsby, Zill‐e‐Huma Latif, Arild Opheim, Peter Krajci, Haase, Kamni Sharma, Jūratė Šaltytė Benth, Lars Tanum, and Nikolaj Kunoe. 2018. “Effectiveness, Safety and Feasibility of Extended‐release Naltrexone for Opioid Dependence: A 9‐month Follow‐up to a 3‐month Randomized Trial.” Addiction 113 (10): 1840–49. doi:10.1111/add.14278.